Tech Company Financing Transactions
Biomica Funding Round
Biomica, based in Park Rehovot, secured $20 million in funding from Shanghai Healthcare Capital.
Transaction Overview
Company Name
Announced On
12/21/2022
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Shanghai Healthcare Capital (Lead Investor)
Proceeds Purpose
Shanghai Healthcare Capital is a leading Chinese private equity fund, based in Shanghai and focused on biotech and healthcare investments globally. The fund's goal is investment in early stage and best-in-class innovators with a pipeline of therapies for improving the lives and long-term outcome of patients. The fund is managed by SIIC Capital, with Shanghai Pharma as one of the founding and strategic Limited Partners.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
13 Gad Feinstein st.
Park Rehovot, Undisclosed
IL
Park Rehovot, Undisclosed
IL
Phone
Website
Email Address
Overview
Biomica is a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics for the treatment of immune-mediated and infectious diseases, with specific focus on Immuno-Oncology and GI related disorders. Biomica's discovery and development efforts are powered by PRISM (Predictive, high Resolution, Integrative Selection of Microbes) platform. PRISM is a proprietary metagenomics analysis platform for functional genomics profiling utilizing internal comprehensive databases.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 12/20/2022: QuantCube Technology venture capital transaction
Next: 12/21/2022: Apeiron Synthesis venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs